Embecta CorpEMBC
Price$5.79Intrinsic value$10.2577% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $10.25median of 5 methods · middle span $10-$12based on filings through 30 Jun 2026
Market Price $5.79Price as of 1 Oct 2026
Margin of Safety +77.0%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: -15.0% (near-term consensus, capped) · years 2–5: -12.4%/yr (balance of the path).-12.9% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 6-9.3%Yr 7-6.2%Yr 8-3.1%Yr 9-0.1%Yr 103.0%
-12.4% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 1 window (5y) (limited history)-26.4%
Discount rate (cost of equity) 8.9%
Volatility vs market (adjusted beta)0.87

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetEmbecta CorpEMBCHealth Care
Valuation
P/E3.9×
P/S0.3×
P/B—
EV / Revenue1.5×
EV / EBITDA4.1×
Profitability
Gross margin57.6%
Operating margin15.8%
Net margin8.6%
FCF margin16.2%
Returns
ROE—
ROA6.9%
ROIC—
Growth
Revenue growth (YoY)-9.3%
5-yr fwd EPS growth-12.9%
Financial strength
Debt / Equity—
Current ratio1.68×
Altman Z-Score1.3
Interest coverage—
Dividend yield14.8%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.